BR100 Decreased By (-0.3%)
BR30 Decreased By (-0.28%)
KSE100 Decreased By (-0.28%)
KSE30 Decreased By (-0.32%)
AGHA 7.80 Decreased By ▼ -0.01 (-0.13%)
BECO 5.17 Decreased By ▼ -0.04 (-0.77%)
BML 57.99 Increased By ▲ 0.49 (0.85%)
BOP 34.20 Increased By ▲ 0.17 (0.5%)
CNERGY 9.88 Decreased By ▼ -0.08 (-0.8%)
CSIL 5.35 Increased By ▲ 0.04 (0.75%)
FCCL 54.51 Decreased By ▼ -0.19 (-0.35%)
FFL 16.61 Decreased By ▼ -0.08 (-0.48%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 7.32 Decreased By ▼ -0.08 (-1.08%)
KOSM 5.72 Decreased By ▼ -0.05 (-0.87%)
LOTCHEM 29.45 Increased By ▲ 0.13 (0.44%)
MLCF 93.49 Decreased By ▼ -0.87 (-0.92%)
NBP 201.95 Decreased By ▼ -1.10 (-0.54%)
NCPL 56.60 Decreased By ▼ -0.40 (-0.7%)
NPL 67.60 Decreased By ▼ -0.10 (-0.15%)
OGDC 316.25 Increased By ▲ 0.41 (0.13%)
PACE 10.67 Increased By ▲ 0.03 (0.28%)
PAEL 42.88 Decreased By ▼ -0.32 (-0.74%)
PIBTL 16.60 Decreased By ▼ -0.14 (-0.84%)
PPL 218.70 Decreased By ▼ -1.08 (-0.49%)
PRL 49.39 Increased By ▲ 0.20 (0.41%)
PTC 70.40 Decreased By ▼ -0.13 (-0.18%)
SSGC 27.84 Decreased By ▼ -0.41 (-1.45%)
TBL 9.73 Decreased By ▼ -0.13 (-1.32%)
TELE 8.72 Decreased By ▼ -0.07 (-0.8%)
TPL 18.11 Decreased By ▼ -0.13 (-0.71%)
TPLP 13.35 Increased By ▲ 0.08 (0.6%)
TREET 22.74 Increased By ▲ 0.02 (0.09%)
TRG 60.00 Decreased By ▼ -0.14 (-0.23%)

ISLAMABAD: Following the response to a letter from Transparency International Pakistan (TIP), the Prime Minister (PM) of Pakistan Shehbaz Sharif has taken serious action to combat the proliferation of fake and substandard medicines in the country.

The Prime Minister has appointed Zeeshan Nazir Bajwa as the new Drug Controller/ Director. Prior to this appointment, Bajwa served as the Deputy Director General at the Drug Regulatory Authority of Pakistan (DRAP).

The appointment was made based on the recommendations of the Central Selection Board and with the approval of the Prime Minister, according to an official notification issued by the Ministry of National Health Services, Regulations and Coordination.

The notification states that Bajwa’s appointment as Drug Controller/ Director (BS-20) is effective immediately. He will be working under DRAP, which operates under the Ministry of National Health Services, Regulations and Coordination. This move signifies the government’s commitment to addressing concerns raised by Transparency International and to ensuring the availability of quality and safe medicines for the citizens of Pakistan.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.